Circulating Tumor Deoxyribonucleic acid (ctDNA) Assay

DIAGNOSTIC_TEST2 trials

Sponsors

University of Miami

Conditions

Metastatic Pancreatic Ductal AdenocarcinomaNon Small Cell Lung CancerPancreatic Ductal Adenocarcinoma

Phase 2

ctDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer

RecruitingNCT06902272

University of MiamiNon Small Cell Lung Cancer

Start: 2025-06-11End: 2029-06-11Target: 30Updated: 2025-07-22

Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma

RecruitingNCT07096362

University of MiamiMetastatic Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma

Start: 2025-09-09End: 2030-09-30Target: 50Updated: 2025-09-23

Related Papers

Utility of ctDNA in early switch of first-line mFOLFIRINOX in metastatic pancreatic ductal adenocarcinoma (mPDAC).

Journal of Clinical Oncology2026-01-10